Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trudi Jones

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ISRN Pharmaceutics|March 6, 2012
Pharmacogenetics and gender association with psychotic episodes on nortriptyline lower doses: patient casesIrina Piatkov, Trudi Jones
Journal of Personalized Medicine|January 7, 2015
Cases of adverse reaction to psychotropic drugs and possible association with pharmacogeneticsIrina Piatkov, Trudi Jones, Mark McLean
Pharmacogenomics|December 5, 2009
Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical applicationIrina Piatkov, Trudi Jones, Colin Rochester
Toxins|November 10, 2011
Warfarin toxicity and individual variability-clinical caseIrina Piatkov, Colin Rochester, Trudi Jones, et al.
Pharmacogenomics and Personalized Medicine|September 19, 2017
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapineIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 1, 2017
CYP2C19*17 protects against metabolic complications of clozapine treatmentIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ISRN Pharmaceutics|March 6, 2012
Pharmacogenetics and gender association with psychotic episodes on nortriptyline lower doses: patient casesIrina Piatkov, Trudi Jones
Journal of Personalized Medicine|January 7, 2015
Cases of adverse reaction to psychotropic drugs and possible association with pharmacogeneticsIrina Piatkov, Trudi Jones, Mark McLean
Pharmacogenomics|December 5, 2009
Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical applicationIrina Piatkov, Trudi Jones, Colin Rochester
Toxins|November 10, 2011
Warfarin toxicity and individual variability-clinical caseIrina Piatkov, Colin Rochester, Trudi Jones, et al.
Pharmacogenomics and Personalized Medicine|September 19, 2017
ABCB1 and ABCC1 single-nucleotide polymorphisms in patients treated with clozapineIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 1, 2017
CYP2C19*17 protects against metabolic complications of clozapine treatmentIrina Piatkov, Dorgival Caetano, Yolinda Assur, et al.
Pageof 1